Smart-Money SignalNeutral · 52/100— Insiders are net buyers over 90 days ($44K, 1 buy vs 0 sales)
Revenue$41.6M
Net Income-$3.4M
EPS$-0.20
Gross Margin51.1%
Market Cap$151.6M
Price Performance
Historical data including institutional events
Company Profile
K
Keith J. Sullivan
CEO & Executive Director
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.